Samsung Medical Center
| République de Corée | Turquie | Espagne | |
| Physiothérapie | de $100 | de $50 | de $300 |
| Thérapie par cellules souches pour la spondylarthrite ankylosante | - | de $7,000 | de $9,000 |
| Thérapie biologique | - | de $5,500 | de $15,000 |
Le Dr Ahn Tae Hoon a été formé au Montreal Heart Institute et dirige le centre cardiovasculaire de l'hôpital Naeun.
Directeur du centre orthopédique de l'hôpital Naeun – spécialisé dans les troubles articulaires et la chirurgie arthroscopique.
Dr. Jang Hyo Kim is an orthopedic surgeon focused on joint preservation and complex reconstruction. He specializes in arthroscopy of the shoulder, knee, ankle, elbow, and wrist. He performs joint replacement of the shoulder, knee, ankle, elbow, and hip. His spine work includes cervical and lumbar instrumentation and fusion. He also performs discectomy, laminectomy, neuroplasty, and vertebroplasty. His practice includes fracture care and muscle and ligament repair.
He is an Adjunct Professor at Kyung Hee University. He serves as Director of the Joint Center at Very Good Hospital. He previously served as chief or director at Yeonggwang General, Songjeong Sarang, Sewoori–Daejeon, Seoul Welfare, and The Barun hospitals. He was an advisory member of the Gwangju–Jeonnam Workers’ Compensation Board. He is a full member of the Korean Orthopaedic Association (KOA) and the Korean Societies of Arthroscopy, Knee, Sports Medicine, Hip, Pain, and Obesity. He holds TPI therapy certification. He completed an Ilizarov fellowship in Kurgan, Russia. He also completed training in shoulder arthroscopy.
South Korea National Health Insurance covers biologics for ankylosing spondylitis under the Rare Intractable Disease program. Patients typically pay only 10% of treatment costs. Coverage requires specific clinical criteria like active sacroiliitis on imaging and failure of conventional therapies after 3 months.
Bookimed Expert Insight: Patients should prioritize university hospitals like Severance or Asan Medical Center for initial biologic approval. These academic centers manage high patient volumes and have streamlined systems for RID registration. Major facilities also utilize digital systems like BESTcare to track treatment history and prevent documentation errors during appeals.
Patient Consensus: Patients note that documenting every medication failure is vital for insurance approval. Many find that while initial drug costs seem high, the 10% co-pay cap makes long-term biologic therapy affordable.